Welcome to LookChem.com Sign In|Join Free

CAS

  • or

953-69-5

Post Buying Request

953-69-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

953-69-5 Usage

Description

Bicyclo[2.2.2]octane-1-carboxylic acid, 4-phenylis a bicyclic chemical compound with the molecular formula C17H20O2. It features a carboxylic acid group and a phenyl group attached to the carbon atom, belonging to the class of organic compounds known as bornanes, which are bicyclic compounds containing a hydrogenated azulene skeleton.

Uses

Used in Pharmaceutical and Medicinal Chemistry:
Bicyclo[2.2.2]octane-1-carboxylic acid, 4-phenylis used as a building block for the synthesis of various derivatives with potential therapeutic properties. Its unique bicyclic structure and functional groups may contribute to its biological activities, making it a promising candidate for the development of new drugs and pharmaceutical agents.

Check Digit Verification of cas no

The CAS Registry Mumber 953-69-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,5 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 953-69:
(5*9)+(4*5)+(3*3)+(2*6)+(1*9)=95
95 % 10 = 5
So 953-69-5 is a valid CAS Registry Number.

953-69-5Relevant articles and documents

LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

-

, (2014/07/23)

Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.

PYRIMIDO- [4, 5-B] -OXAZINES FOR USE AS DGAT INHIBITORS

-

Page/Page column 36, (2008/06/13)

Formula (I). Compounds of formula (I) or salts thereof, wherein A1, and R1 to R5 are as defined in the specification, are DGAT-1 inhibitors and are thereby useful in the treatment of, for example, obesity. Processes to make compounds of formula (I) are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 953-69-5